The findings demonstrate a consistent direction of effect across studies, supporting the hypothesis that GLP-1 RAs significantly reduce symptoms of alcohol use disorder (AUD), as measured by the AUDIT score. The gene discussed is GLP1R; the disease is alcohol abuse.